Munich, Bavaria, Germany
I have a track record of building and running commercial operations in Pharma and Life Sciences Services, developing national and international marketing and business strategies, and growing business based on a clear strategy and focus on operational excellence. With a deep interest and understanding of science and technology I have accumulated experience in various therapeutic areas, including oncology, transplantation, immunology, cardiology, gastroenterology, nephrology, infectious diseases, dermatology, and rare diseases. In addition, I have worked on the forefront of digital health and implementation of genAI into business and services. Currently, I am the CEO of iOMEDICO, an independent institute with an exclusive focus on oncology and hematology. I lead a team of experts who offer strategic advice and clinical research services to stakeholders engaged in improving patient care in oncology and hematology, leveraging our access to over 70,000 clinical trial grade longitudinal, prospectively collected patient datasets across various cancer entities. General Management • Consultancy • P&L / Business Management • Market Access and Pricing • Strategic Marketing • Brand Launch and LCM • Business start-up • Alliance Management • Business Development • Drug Development • Cross-Cultural Management • Industry Associations • Stakeholder Management • eHealth • Digital Therapeutics • genAI • Healthtech
iOMEDICO is an independent research institute with an exclusive focus on oncology and hematology. Our team of experts offer strategic advice on improvement of care pathways including clinical trial designs and market access support. With over 70.000 clinical trial grade longitudinal, prospectively collected patient datasets across various cancer entities iOMEDICO is a leading data and knowledge provider for stakeholders engaged in improving patient care in oncology and hematology. iOMEDICO also offers clinical research services (phase I to IV, non-interventional studies) through an existing network of over 1.000 oncology and hematology research sites, allowing for accelerated project implementation and recruitment. The research network is also specialized in identifying rare disease types.
Pharma consultancy: Operations set-up in Germany/Europe, market access preparation and go to market strategy